Mostrar el registro sencillo del ítem

dc.contributor.authorLakoh, S.
dc.contributor.authorJiba, D. F.
dc.contributor.authorAdekanmbi, O.
dc.contributor.authorPoveda López, Eva 
dc.contributor.authorSahr, F.
dc.contributor.authorDeen, G. F.
dc.contributor.authorForay, L. M.
dc.contributor.authorGashau, W.
dc.contributor.authorHoffmann, C. J.
dc.contributor.authorSalata, R. A.
dc.contributor.authorYendewa, G. A.
dc.date.accessioned2022-05-24T12:13:21Z
dc.date.available2022-05-24T12:13:21Z
dc.date.issued2020
dc.identifier.issn1201-9712
dc.identifier.otherhttps://www.ncbi.nlm.nih.gov/pubmed/32339724es
dc.identifier.urihttp://hdl.handle.net/20.500.11940/16818
dc.description.abstractOBJECTIVE: To assess the diagnosis, treatment outcomes, and predictors of mortality in adult tuberculosis (TB) patients in an urban setting with a high HIV prevalence. METHODS: A retrospective study was conducted of adult TB patients aged >/=15 years who were treated at Connaught Hospital in Freetown, Sierra Leone from January through December 2017. Multivariate logistic regression was used to identify predictors of mortality. RESULTS: Of 1127 TB cases notified in 2017, 1105 (98%) were tested for HIV, yielding a TB/HIV co-infection rate of 32.0%. Only HIV-tested cases (n=1105) were included in the final analysis. The majority were male (69.3%), aged 25-34 years (29.2%), and had pulmonary TB (96.3%). Treatment outcomes were as follows: 29.0% cured, 29.0% completed, 0.5% treatment failure, 24.2% lost to follow-up, 12.8% transferred/not evaluated, and 4.5% died. The majority of deaths (80.0%, 40/50) occurred within 2 months of TB treatment initiation. Age 65 years or older (adjusted odds ratio 3.48, 95% confidence interval 1.15-10.56; p=0.027) and HIV-positive status (adjusted odds ratio 3.50, 95% confidence interval 1.72-7.12; p=0.001) were independent predictors of mortality. CONCLUSIONS: Suboptimal TB treatment outcomes were observed in Sierra Leone in 2017. More local and international action is warranted to help achieve the 2035 global TB elimination targets.en
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.meshAdult*
dc.subject.meshMiddle Aged*
dc.subject.meshAdolescent*
dc.subject.meshCoinfection*
dc.subject.meshTuberculosis*
dc.subject.meshPrevalence*
dc.subject.meshHumans*
dc.subject.meshTreatment Outcome*
dc.subject.meshDiagnosis*
dc.subject.meshYoung Adult*
dc.subject.meshAged*
dc.subject.meshRetrospective Studies*
dc.subject.meshHIV Infections*
dc.subject.meshCities*
dc.titleDiagnosis and treatment outcomes of adult tuberculosis in an urban setting with high HIV prevalence in Sierra Leone: A retrospective studyen
dc.typeJournal Articlees
dc.authorsophosLakoh, S.;Jiba, D. F.;Adekanmbi, O.;Poveda, E.;Sahr, F.;Deen, G. F.;Foray, L. M.;Gashau, W.;Hoffmann, C. J.;Salata, R. A.;Yendewa, G. A.
dc.identifier.doi10.1016/j.ijid.2020.04.038
dc.identifier.pmid32339724
dc.identifier.sophos41329
dc.journal.titleINTERNATIONAL JOURNAL OF INFECTIOUS DISEASESes
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::Instituto de Investigación Biomédica Ourense-Pontevedra-Vigo (IBI)es
dc.page.initial112es
dc.page.final118es
dc.rights.accessRightsopenAccess
dc.subject.decsresultado del tratamiento*
dc.subject.decsprevalencia*
dc.subject.decsestudios retrospectivos*
dc.subject.decsmediana edad*
dc.subject.decscoinfección*
dc.subject.decsadulto*
dc.subject.decsinfecciones por VIH*
dc.subject.decsanciano*
dc.subject.decstuberculosis*
dc.subject.decsdiagnóstico*
dc.subject.decsciudades*
dc.subject.decsadulto joven*
dc.subject.decshumanos*
dc.subject.decsadolescente*
dc.subject.keywordIISGSes
dc.typefidesArtículo Originales
dc.typesophosArtículo Originales
dc.volume.number96.es


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 International
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 International